We are live on ! Find out more
Neuberger Berman Group

Neuberger Berman Group Portfolio holdings

AUM $131B
1-Year Est. Return 28.36%
This Fund
S&P 500
This Quarter Est. Return
+25.27%
1 Year Est. Return
+28.36%
3 Year Est. Return
+86.21%
5 Year Est. Return
+112.87%
10 Year Est. Return
+467.9%
AUM
$80.5B
AUM Growth
+$14.9B
Cap. Flow
-$1.65B
Cap. Flow %
-2.05%
Top 10 Hldgs %
14.87%
Holding
1,659
New
136
Increased
550
Reduced
732
Closed
126

Sector Composition

Rank Sector Weight
1 Technology 25.81%
2 Financials 13.12%
3 Healthcare 12.53%
4 Consumer Discretionary 10%
5 Industrials 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRC icon
1026
Tejon Ranch
TRC
$476M
$1.67M ﹤0.01%
115,860
-7,820
-6% -$109K
LGF.A
1027
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$1.66M ﹤0.01%
224,225
+29,542
+15% +$219K
AUY
1028
DELISTED
Yamana Gold, Inc.
AUY
$1.66M ﹤0.01%
306,080
+274,147
+859% +$1.31M
APTS
1029
DELISTED
Preferred Apartment Communities, Inc.
APTS
$1.66M ﹤0.01%
217,853
-56,655
-21% -$411K
CERN
1030
DELISTED
Cerner Corp
CERN
$1.65M ﹤0.01%
24,069
-7,881
-25% -$542K
LSI
1031
DELISTED
Life Storage, Inc.
LSI
$1.63M ﹤0.01%
25,706
+5,099
+25% +$316K
GLPI icon
1032
Gaming and Leisure Properties
GLPI
$12.8B
$1.62M ﹤0.01%
46,894
-31,250
-40% -$973K
SNY icon
1033
Sanofi
SNY
$104B
$1.62M ﹤0.01%
31,710
-7,287
-19% -$354K
RMD icon
1034
ResMed
RMD
$28.3B
$1.62M ﹤0.01%
8,491
-493
-5% -$80.7K
REAL icon
1035
The RealReal
REAL
$1.34B
$1.61M ﹤0.01%
125,987
-47,358
-27% -$564K
TECX
1036
Tectonic Therapeutic
TECX
$573M
$1.6M ﹤0.01%
7,667
+2,834
+59% +$584K
C icon
1037
CALL
Citigroup
C
$222B
$1.59M ﹤0.01%
+2,500
New +$119K
GRP.U
1038
DELISTED
Granite Real Estate Investment Trust
GRP.U
$1.59M ﹤0.01%
30,937
+16,733
+118% +$784K
AVLR
1039
DELISTED
Avalara, Inc.
AVLR
$1.58M ﹤0.01%
11,857
-39,763
-77% -$3.91M
VAC icon
1040
Marriott Vacations Worldwide
VAC
$3.24B
$1.57M ﹤0.01%
19,149
+5,998
+46% +$489K
TRTN
1041
DELISTED
Triton International Limited
TRTN
$1.57M ﹤0.01%
52,030
-6,906
-12% -$205K
WLY icon
1042
John Wiley & Sons Class A
WLY
$2.52B
$1.57M ﹤0.01%
40,234
-2,908
-7% -$111K
RARE icon
1043
Ultragenyx Pharmaceutical
RARE
$2.65B
$1.56M ﹤0.01%
20,000
-2,000
-9% -$132K
OEC icon
1044
Orion
OEC
$394M
$1.55M ﹤0.01%
146,047
-17,600
-11% -$163K
CDLX icon
1045
Cardlytics
CDLX
$21M
$1.54M ﹤0.01%
2,200
-2,200
-50% -$1.27M
SJM icon
1046
J.M. Smucker
SJM
$12.6B
$1.54M ﹤0.01%
14,548
-432
-3% -$48.5K
ACGL icon
1047
Arch Capital
ACGL
$36.1B
$1.53M ﹤0.01%
53,425
-1,829
-3% -$50.6K
GLOB icon
1048
Globant
GLOB
$1.35B
$1.52M ﹤0.01%
10,157
-12,000
-54% -$1.48M
ADM icon
1049
Archer Daniels Midland
ADM
$41.4B
$1.52M ﹤0.01%
38,227
+11,213
+42% +$420K
KMI icon
1050
Kinder Morgan
KMI
$73.1B
$1.51M ﹤0.01%
100,416
-61,608
-38% -$936K

Similar funds

Neuberger Berman Group's Q2 2020 Portfolio in Review

As of Q2 2020, Neuberger Berman Group held 1,659 positions worth $80.5B, up 23% from $65.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Neuberger Berman Group's Q2 2020 filing shows 136 new, 550 increased, 732 reduced and 126 closed positions. Its largest new stake was Biora Therapeutics, Inc. Common Stock: 26,164 shares worth $58.9M. The largest sale was Proofpoint, Inc., an estimated $121M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Neuberger Berman Group's largest Q2 2020 buy was Biora Therapeutics, Inc. Common Stock: 26,164 shares worth $58.9M.
  • Neuberger Berman Group added most to TJX Companies in Q2 2020, an estimated $163M increase.
  • Neuberger Berman Group's biggest Q2 2020 reduction was Proofpoint, Inc., cutting an estimated $121M.
  • Neuberger Berman Group fully exited Allergan plc in Q2 2020, selling an estimated $116M.
  • Neuberger Berman Group's ten largest holdings make up 15% of its $80.5B portfolio in Q2 2020.
  • Neuberger Berman Group opened 136 new positions and closed 126 in Q2 2020.
  • Neuberger Berman Group's portfolio value rose 23% quarter-over-quarter to $80.5B.

Based on Neuberger Berman Group's 13F filing for Q2 2020, filed 13 Aug 2020.